SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/11/22 AeroClean Technologies, Inc. S-1 4:1M Toppan Merrill/FA |
Document/Exhibit Description Pages Size 1: S-1 Registration Statement (General Form) HTML 491K 2: EX-5.1 Opinion of Counsel re: Legality HTML 13K 3: EX-23.1 Consent of Expert or Counsel HTML 5K 4: EX-FILING FEES Filing Fees HTML 11K
tm2220550-1_s1 - none - 11.7500505s |
|
Delaware
(State or other jurisdiction of
incorporation or organization) |
| |
3841
(Primary Standard Industrial
Classification Code Number) |
| |
45-3213164
(I.R.S. Employer
Identification Number) |
|
| | |
Jason DiBona
c/o AeroClean Technologies, Inc. 10455 Riverside Drive Palm Beach Gardens, FL 33410 Telephone: (833) 652-5326 |
|
|
Large accelerated filer
☐
|
| |
Accelerated filer
☐
|
|
|
Non-accelerated filer
☒
|
| |
Smaller reporting company
☒
|
|
| | | |
Emerging growth company
☒
|
|
| | |
Page
|
| |||
| | | | ii | | | |
| | | | 1 | | | |
| | | | 16 | | | |
| | | | 32 | | | |
| | | | 33 | | | |
| | | | 34 | | | |
| | | | 35 | | | |
| | | | 50 | | | |
| | | | 52 | | | |
| | | | 58 | | | |
| | | | 60 | | | |
| | | | 62 | | | |
| | | | 65 | | | |
| | | | 66 | | | |
| | | | 67 | | | |
| | | | 69 | | | |
| | | | 69 | | | |
| | | | 69 | | | |
| | | | 69 | | |
| | |
Three Months Ended March 31,
|
| |
Year Ended December 31,
|
| ||||||||||||||||||
| | | | |
2021
|
| |
2021
|
| |
2020
|
| |||||||||||||
Operating Data: | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating expenses
|
| | | $ | 2,673,707 | | | | | $ | 1,969,692 | | | | | $ | 8,521,360 | | | | | $ | 3,323,081 | | |
Net loss
|
| | | | (2,577,964) | | | | | | (1,969,692) | | | | | | (7,923,607) | | | | | | (3,323,081) | | |
| | |
As of March 31,
|
| |
As of December 31,
|
| ||||||||||||
| | | | |
2021
|
| |
2020
|
| ||||||||||
Balance Sheet Data: | | | | | | | | | | | | | | | | | | | |
Cash
|
| | | $ | 17,774,097 | | | | | $ | 19,629,649 | | | | | $ | 2,333,117 | | |
Total assets
|
| | | | 21,459,419 | | | | | | 23,722,748 | | | | | | 3,193,175 | | |
Total liabilities
|
| | | | 1,656,130 | | | | | | 2,012,333 | | | | | | 665,308 | | |
Total members’/stockholders’ equity
|
| | | | 19,803,289 | | | | | | 21,710,415 | | | | | | 2,527,867 | | |
Name
|
| |
Age
|
| |
Position
|
|
Amin J. Khoury, PhD (Hon) | | |
83
|
| | Co-Founder, Chairman | |
David Helfet, M.D. | | |
74
|
| | Co-Founder, Chief Medical Officer, Director | |
Mark Krosney | | |
75
|
| | Co-Founder, Chief Scientific Officer | |
Jason DiBona | | |
51
|
| | Chief Executive Officer | |
Ryan Tyler | | |
38
|
| | Chief Financial Officer | |
Michael Senft | | |
63
|
| | Lead Independent Director | |
Thomas P. McCaffrey | | |
68
|
| | Director | |
Heather Floyd | | |
43
|
| | Director | |
Timothy J. Scannell | | |
57
|
| | Director | |
Jimmy Thompson | | |
57
|
| | Vice President of Strategic Sales | |
Edward Lanzilotta, PhD | | |
61
|
| | Director of Engineering & Product Development | |
Nick DeAngelis, PhD | | |
82
|
| | Director of Regulatory Affairs & Quality | |
Rao Tella | | |
74
|
| | Director of Operations | |
Bill Reisenauer | | |
63
|
| | Lead Engineer on Pūrgo UV Subsystem Design | |
Karl Keppeler | | |
48
|
| | Lead Engineer on the Electrical Engineering & Embedded Software Subsystems | |
Joseph Toro | | |
52
|
| | Lead Industrial Design Engineer | |
Name of Beneficial Owner
|
| |
Shares
Beneficially Owned |
| |
Percentage of Shares
Beneficially Owned |
| ||||||
5% Stockholders | | | | | | | | | | | | | |
Lewis Pell(1)
|
| | | | 1,569,060 | | | | | | 10.2% | | |
Dateline TV Holdings, Inc.(2)
|
| | | | 1,198,062 | | | | | | 7.8% | | |
Armistice Capital Master Fund Ltd.(3)
|
| | | | 1,500,000 | | | | | | 9.7% | | |
Northeastern University(4)
|
| | | | 1,500,000 | | | | | | 9.7% | | |
Named Executive Officers and Directors | | | | | | | | | | | | | |
Amin J. Khoury(5)
|
| | | | 4,119,793 | | | | | | 26.7% | | |
David Helfet, M.D.(6)
|
| | | | 759,590 | | | | | | 4.9% | | |
Mark Krosney
|
| | | | 256,728 | | | | | | 1.7% | | |
| | | | 37,862 | | | | | | * | | | |
| | | | 186,509 | | | | | | 1.2% | | | |
| | | | — | | | | | | — | | | |
Timothy Scannell(10)
|
| | | | — | | | | | | — | | |
Jason DiBona(11)
|
| | | | — | | | | | | — | | |
Ryan Tyler(12)
|
| | | | — | | | | | | — | | |
All Executive Officers and Directors as a Group (9 persons)
|
| | | | 5,360,482 | | | | | | 34.8% | | |
Name of
Selling Stockholder |
| |
Number of shares of
Common Stock Owned Prior to Offering |
| |
Maximum Number of
Shares of Common Stock to be Sold Pursuant to this Prospectus |
| |
Number of Shares of
Common Stock Owned After Offering |
| |||||||||
| | | | 3,000,000(1) | | | | | | 3,000,000 | | | | | | __ | | |
| | |
Amount to
be paid |
| |||
SEC registration fee
|
| | | $ | 3,526 | | |
Accounting fees and expenses
|
| | | $ | 10,000 | | |
Legal fees and expenses
|
| | | | 75,000 | | |
FINRA filing fee
|
| | | | 6,247 | | |
Total
|
| | | $ | 94,773 | | |
Exhibit No.
|
| |
Exhibit Description
|
|
10.15 | | | | |
23.1* | | | | |
23.2* | | | | |
24.1* | | | Power of Attorney (included on signature page) | |
107* | | | |
|
Signature
|
| |
Title
|
| |
Date
|
|
|
/s/ Jason DiBona
|
| |
Chief Executive Officer
(Principal Executive Officer) |
| | | |
|
/s/ Ryan Tyler
|
| |
Chief Financial Officer
(Principal Financial Officer) |
| | | |
|
/s/ Amin Khoury
Amin J. Khoury, PhD (Hon)
|
| |
Chairman of the Board
|
| | | |
|
/s/ David Helfet
David Helfet, M.D.
|
| |
Director
|
| | | |
|
/s/ Michael Senft
|
| |
Director
|
| | | |
|
|
| |
Director
|
| | |
|
Signature
|
| |
Title
|
| |
Date
|
|
|
/s/ Heather Floyd
|
| |
Director
|
| | | |
|
|
| |
Director
|
| | |
This ‘S-1’ Filing | Date | Other Filings | ||
---|---|---|---|---|
9/27/27 | ||||
12/31/22 | ||||
11/29/22 | ||||
9/27/22 | ||||
Filed on: | 7/11/22 | D, SC 13G | ||
7/8/22 | ||||
7/1/22 | ||||
6/29/22 | 1-A-W | |||
6/26/22 | 8-K | |||
6/1/22 | 4 | |||
5/11/22 | 3, 4, 8-K, SC 13G/A | |||
3/31/22 | 10-Q, 8-K, NT 10-K | |||
2/14/22 | SC 13G | |||
12/31/21 | 10-K, 10-K/A, NT 10-K | |||
12/1/21 | 4 | |||
11/29/21 | 4, S-8 | |||
11/5/21 | ||||
9/30/21 | 10-Q, 10-Q/A | |||
3/31/21 | ||||
3/11/21 | ||||
3/1/21 | ||||
12/31/20 | ||||
4/30/20 | ||||
4/22/20 | ||||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/20/22 Molekule Group, Inc. S-1/A 1:964K Toppan Merrill/FA |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/30/22 Molekule Group, Inc. 8-K:1,3,8,9 6/26/22 16:901K Toppan Merrill/FA 5/12/22 Molekule Group, Inc. 10-Q 3/31/22 52:2.7M Toppan Merrill/FA 5/12/22 Molekule Group, Inc. 8-K:2,5,9 5/11/22 11:289K Toppan Merrill/FA 4/01/22 Molekule Group, Inc. 10-K 12/31/21 65:4.2M Toppan Merrill/FA 11/29/21 Molekule Group, Inc. S-8 11/29/21 8:527K Toppan Merrill/FA 11/29/21 Molekule Group, Inc. S-8 11/29/21 7:453K Toppan Merrill/FA 11/19/21 Molekule Group, Inc. 8-A12B 1:14K Toppan Merrill/FA 10/08/21 Molekule Group, Inc. 1-A/A 6:1.7M Toppan Merrill/FA 9/21/21 Molekule Group, Inc. 1-A 4:1.1M Toppan Merrill/FA 9/03/21 Molekule Group, Inc. DOS/A¶ 9/21/21 19:2M Toppan Merrill/FA |